Ireland
--:--IST
Recruiting Not applicable

Effect of Dance on the Parameters of the ICF in Children With Functional Diversity

NCT07166055 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-09-15
Last updated
2025-09-10

Condition(s) studied

Children With Disabilities

Investigational drug(s) / intervention(s)

Therapeutic dance

Therapeutic dance: The protocol includes two sessions per week of therapeutic dance, during the months of October to May.

Study summary

The goal of this clinical trial is to determine the effect of a therapeutic dance program developed in a school environment on different parameters of structure and function, activity and participation according to the ICF framework in children with functional diversity.

Researchers will compare the effects of eight months of therapeutic dance classes (consisting of two one-hour sessions per week) on ICF parameters to the effects of no intervention.

Eligibility

Sex
ALL
Min age
3 Years
Max age
14 Years
Healthy volunteers
Accepted
Inclusion Criteria: * children with motor impairment * aged between 3-14 years, * who can cognitively follow simple tasks Exclusion Criteria: * having suffered a serious clinical condition or surgical intervention in the last 6 months.

Primary outcome measure(s)

  • The Canadian Occupational Performance Measure (COPM). — Baseline (pre-intervention) and immediately post-intervention.
    Is an evidence-based outcome measure designed to capture a client's self-perception of performance in everyday living, over time.
  • Goal Attainment Scale (GAS). — Baseline (pre-intervention) and immediately post-intervention.
    Goal Attainment Scaling (GAS) is a method of scoring the extent to which patient's individual goals are achieved in the course of intervention.

Trial sites (1)

FacilityCityRegionStatus
University of Valencia Valencia Spain Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07166055 on ClinicalTrials.gov ↗ ← All trials in Spain